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Abstract
Neisseria meningitidis serogroup B (MnB) was responsible for two independent meningococcal disease outbreaks at
universities in the USA during 2013. The first at University A in New Jersey included nine confirmed cases reported between
March 2013 and March 2014. The second outbreak occurred at University B in California, with four confirmed cases during
November 2013. The public health response to these outbreaks included the approval and deployment of a serogroup B
meningococcal vaccine that was not yet licensed in the USA. This study investigated the use of whole-genome sequencing
(WGS) to examine the genetic profile of the disease-causing outbreak isolates at each university. Comparative WGS revealed
differences in evolutionary patterns between the two disease outbreaks. The University A outbreak isolates were very closely
related, with differences primarily attributed to single nucleotide polymorphisms/insertion-deletion (SNP/indel) events. In
contrast, the University B outbreak isolates segregated into two phylogenetic clades, differing in large part due to
recombination events covering extensive regions (>30 kb) of the genome including virulence factors. This high-resolution
comparison of two meningococcal disease outbreaks further demonstrates the genetic complexity of meningococcal bacteria
as related to evolution and disease virulence.
DATA SUMMARY
Assembled contigs of isolates have been deposited in Gen-
Bank, BioProject ID: PRJNA395340 (http://www.ncbi.nlm.
nih.gov/bioproject/395340).
INTRODUCTION
Meningococcal disease has a rapid onset and potentially
devastating consequences, with high case-fatality rates as
well as significant sequelae amongst survivors [1]. In devel-
oped countries, disease incidence is highest in infants and
young children (<5 years of age), but peaks again among
adolescents and young adults [2, 3]. Groups at increased
risk include military recruits and students residing in close
quarters such as dormitories [4]. Neisseria meningitidis, a
leading cause of bacterial meningitis, is classified into 12
serogroups defined by the structure of the capsular polysac-
charide [2]. Licensed capsular polysaccharide and capsular
polysaccharide conjugate vaccines provide protection
against four of the major invasive serogroups (A, C, Y and
W) [2]. In contrast, the N. meningitidis serogroup B (MnB)
polysaccharide is composed of polysialic acid repeating
units that are similar to structures found on human neuro-
nal cells (particularly during fetal development) and are not
suitable as vaccine antigens [5]. Two licensed MnB vaccines
[6, 7] are instead comprised of outer-membrane protein
antigens.
Meningococcal disease outbreaks that occur at universities
can pose significant challenges for infection control and
health management due to social behaviour tendencies of
young adults and the size and dynamics of the student pop-
ulation. In the USA, students entering college have been
recommended to receive a quadrivalent meningococcal con-
jugate vaccine (MenACWY) since 2000. Since this time, the
incidence of invasive infection from these serogroups has
declined [8, 9]. However, vaccines providing protection
against serogroup B were not commercially available in the
USA until late 2014. Since 2008, MnB outbreaks have been
reported in at least eight different universities across the
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USA [10]. The Centers for Disease Control and Prevention
(CDC) has recently modified the definition of what consti-
tutes an outbreak of N. meningitidis serogroup B disease to
include 2 cases in an organization with a population
of <5000 people (or 3 cases in a population 5000 people)
in a period of 6months or less (https://www.cdc.gov/menin-
gococcal/outbreaks/).
During 2013, MnB disease outbreaks were reported at
two universities in the USA (https://www.cdc.gov/vaccines/
acip/meetings/downloads/min-archive/min-2014-10.pdf).
Between March 2013 and March 2014, seven students at
University A and two individuals with epidemiologic links
to University A students were diagnosed with meningococ-
cal disease and serogroup B strains were recovered from
eight cases. Cases of disease were protracted over
two academic years. Disease incidence at this university
reached 134/100 000 population, nearly 1400 times greater
than the disease incidence expected in the USA at the time
[11]. Four cases of meningococcal serogroup B disease were
identified at University B during November 2013. As a
result of these two outbreaks, 4CMenB, a serogroup B vac-
cine that at the time was only licensed ex-USA, was
deployed under an Investigational New Drug (IND) appli-
cation to prevent further cases [11, 12]. In response to these
two university outbreaks, the MnB vaccines Trumenba
(bivalent rLP2086) and Bexsero (4CMenB) [13] were
granted accelerated approval by the US Food and Drug
Administration (FDA) for individuals 10 years of age in
October 2014 and February 2015, respectively [6, 7].
N. meningitidis infections are considered as reportable
diseases in many regions of the developed world. As part
of routine microbiological surveillance for the purpose of
monitoring disease prevalence and outbreak control,
strains are also typed genetically. Historically, pulsed-field
gel electrophoresis (PFGE) profiling of bacterial strains
has been used widely for outbreak investigations [14, 15].
More recently, sequence-based genetic typing techniques
such as multi-locus sequence typing (MLST) [16] and
fine typing of individual virulence factors such as porin A
(PorA) and porin B (PorB) have been used for global sur-
veillance of this pathogen [17]. However, isolates collected
from a disease outbreak are typically highly related and
traditional molecular typing approaches are unable to
provide sufficient resolution for detailed comparative
analysis.
The rapid advancement of next-generation sequencing
(NGS) technology and the development of sequence assem-
bly algorithms have transformed the way molecular epide-
miology is used to study populations of bacterial pathogens.
Recent studies [18–20] illustrated the value of whole-
genome sequencing (WGS) in rapid, accurate and compre-
hensive characterization of bacterial strains in clinical
settings. WGS provides ultimate resolution and an opportu-
nity to differentiate highly related strains and, therefore,
enhance disease surveillance. Here, we present a retrospec-
tive analysis of meningococcal isolates from these two
university outbreaks using WGS data to define the related-
ness and evolutionary patterns within the respective subpo-
pulations of outbreak disease isolates.
METHODS
N. meningitidis outbreak and non-outbreak
reference isolates
Meningococcal isolates included in this study were initially
identified and characterized at state public health laborato-
ries, after which isolates were sent to the CDC and con-
firmed by slide agglutination serogrouping and real-time
PCR [21].
Eleven MnB isolates from eight of the individuals diagnosed
with meningococcal disease at University A [March 2013 to
March 2014, including independent isolates from the blood
and cerebrospinal fluid (CSF) of 3 patients] were collected.
Four MnB isolates were collected from students at Univer-
sity B, a single isolate from each of the four patients diag-
nosed with meningococcal disease during November 2013,
together with an outbreak-associated isolate (PMB5018)
collected in March 2013 from a fifth patient affiliated with
the same university.
MnB isolate PMB5266 was selected as a reference for the
University A outbreak. This isolate was originally collected
from a patient diagnosed with meningococcal disease dur-
ing 2013 in the USA and with no known epidemiologic link
with University A. It was selected as it shares the same
sequence type (ST), porB and fetA genotype as the Univer-
sity A outbreak isolates. MnB isolate M5178 was selected as
the reference for the University B outbreak. Isolated in 1998
OUTCOME
Meningococcal disease outbreaks in universities, the mil-
itary and other organization-based settings present a
significant public health concern. Genetic characteriza-
tion of outbreak isolates can provide important insight
into the origin and mechanism(s) of virulence of the bac-
teria, as well as providing information that can potentially
impact infection control and vaccine design. Reported
here is a case study using whole-genome sequencing
(WGS) to analyse disease strains from two independent
university outbreaks in the USA. Detailed comparison of
WGS data identified distinct evolutionary patterns
between the two groups of outbreak strains. Most nota-
bly, examples of homologous recombination events
were evident among disease outbreak isolates from one
university but not the second, where all outbreak isolates
could be attributed to a single phylogenetic clade. This
study also illustrates that a combination of both short-
and long-read WGS platforms can add significant value
to the genetic investigation of the epidemiology of dis-
ease outbreaks.
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from a patient in Oregon with meningococcal disease,
M5178 shares the same ST, porB and fetA genotype as the
University B outbreak isolates.
Molecular typing of outbreak isolates
Additional strain characterization, including PFGE,
MLST and molecular typing of genes coding for factor H
binding protein (fHBP), Neisseria adhesin A (NadA), Neis-
serial heparin binding antigen (NHBA) and porin A (PorA)
was performed as described previously [15, 22, 23].
Whole-genome sequencing
MiSeq, WGS
Genomic DNA from all outbreak and outbreak-associated
MnB isolates was extracted and then sequenced on the Illu-
mina MiSeq, with 2250 bp paired-end sequencing chemis-
try as described previously [20].
PacBio WGS
Three of the outbreak isolates (a single representative from
the University A outbreak and two from the University B
outbreak) and PMB5266 (the University A reference strain)
were selected to be sequenced with the Pacific Biosciences
(PacBio) RSII instrument using P4-C2 sequencing
chemistry. Genomic DNA was extracted using
an ArchivePure DNA purification kit (5 PRIME) according
to the manufacturer’s instructions. One SMRT Cell was run
per isolate. The average read length was 6440.75 bp, and the
average number of reads was 105 464 per SMRT Cell.
Genomic analysis of outbreak strains
For MiSeq data, de novo assembly was performed using the
CLC Genomic Workbench (v. 6.5.1) with default settings.
Generally, the assembled MnB genomes contained 200–300
contigs, with a total size of ~2Mbp per genome. The cover-
age depth ranged between 60 and 329 (Table S1, avail-
able in the online version of this article). The PacBio data
was assembled using PacBio’s Hierarchical Genome
Assembly Process v3 (HGAP). Three of the isolates were
assembled into a single contig, while the fourth was assem-
bled into four contigs. The average coverage was 128
(Table S2).
The BIGSdb (Bacterial Isolate Genome Sequence Database)
[24] was implemented to extract and characterize genetic
information corresponding to targets of interest, including
genes in the capsular polysaccharide biosynthetic operon,
housekeeping genes for MLST, porA, porB, fetA and genes
coding for the protein antigens (fHBP, NadA and NHBA)
of licensed MnB vaccines.
Reads from MiSeq data were mapped to the PacBio refer-
ence genomes using SMALT (http://www.sanger.ac.uk/
resources/software/smalt/), and single-nucleotide polymor-
phisms (SNPs) were identified as described previously [25].
Insertions/deletions (indels) in the mapped data were
detected using GATK [26]. Concatenated SNPs identified
from genome-wide comparisons (excluding recombination
regions) were used to generate a maximal-likelihood tree
using RAxML [27]. Recombination events were identified
using Gubbins (http://sanger-pathogens.github.io/gubbins/)
[28]. Manual inspection of the mapped data in the BAM
files using Artemis [29] was used to confirm the prediction
of the SNPs and indel regions identified.
RESULTS
Genetic analysis of University A outbreak isolates
Traditional molecular typing methods (PFGE and gene-
specific sequence typing) were initially performed for each
of the University A outbreak isolates. All 11 isolates col-
lected from the eight patients shared the same profile: PFGE
pattern 429, ST/clonal complex (CC) ST-409: CC41/44/
Lineage3, PorA variant type P1.5-1,2-2, PorB variant type 3-
82 and FetA variant type F1-5 (Table 1), illustrating the
considerable genetic similarity among these outbreak iso-
lates. As described previously [11], antigens associated with
serogroup B vaccines were also identical among the 11 iso-
lates: fHBP variant B153 (pubmlst variant: 276), NHBA
peptide variant 2, PorA P1.5-1,2-2 and an absence of the
gene coding for NadA.
The MnB invasive disease isolate, PMB5266, which was not
part of the University A outbreak, was selected as a refer-
ence strain as it shared several genetic markers with the out-
break isolates, including MLST/CC, PorB, NHBA and
NadA variant types. Comparative whole-genome SNP-
based phylogenetic analysis (Fig. 1a) indicated that all 11
University A outbreak isolates were grouped into a tight
cluster, well separated from PMB5266. In contrast to the
numerous genetic changes identified between the outbreak
isolates and the reference strain, detailed genome compari-
sons uncovered a total of just 18 SNPs (13 non-synony-
mous, 2 synonymous, 2 intergenic, 1 promoter region),
seven indel events and one recombination event that
distinguished the group of 11 outbreak isolates among
Table 1. Molecular typing results for the University A outbreak
isolates*
Patient ID Strain ID Source of specimen
P1 PMB5024 CSF
P2 PMB5023 CSF
P3 PMB5021 Blood
P3 PMB5022 CSF
P4 PMB5025 CSF
P5 PMB5026 Blood
P6 PMB5027 CSF
P6 PMB5028 Blood
P7 PMB5029 Blood
P7 PMB5030 CSF
P8 PMB5301 Blood
*All 11 isolates had the following profile: PFGE pattern, 429; ST/CC,
ST-409: CC41/44/Lineage3; PorA variant type (VR1,VR2), P1.5-1,2-2;
PorB variant type, 3-82; FetA variant type, F1-5; fHBP variant,
B153; NHBA peptide, variant 2; NadA variant, null.
Hao et al., Microbial Genomics 2018;4
3
Downloaded from www.microbiologyresearch.org by
IP:  138.251.238.152
On: Wed, 18 Apr 2018 07:59:41
themselves. The large contigs generated from the PacBio
assembly of the PMB5026 outbreak isolate allowed for
detailed mapping of individual genetic changes among the
outbreak isolates. A genetic transmission map was recon-
structed after integrating genetic and epidemiology data
(Fig. 1b). Non-synonymous changes associated with genes
involved in amino acid and lipid biosynthesis, such as
ilvD_1 (dihydroxy-acid dehydratase), lpxC (UDP-3-O-acyl-
acetylglucosamine deacetylase), htrB_1 (lipidA biosynthesis
lauroyl acyltransferase) and lptG (lipopolysaccharide export
system permease protein), were identified among the 11
outbreak isolates. Two strains (one each from blood and
CSF) were isolated from each of three University A patients
(P3, P6 and P7). High-resolution analysis of each pair of
Fig. 1. Whole-genome sequence based phylogeny and genetic transmission map among outbreak isolates from University A. (a) Maxi-
mum-likelihood phylogenetic tree generated using concatenated SNPs derived from genome-wide comparison (recombination events
excluded). Scale bar relates branch length to the number of genetic changes. Isolate PMB5266 represents the MnB disease isolate
that does not belong to the outbreak epidemic. For convenience of visualization, the long branch between PMB5266 and University A
outbreak isolates was collapsed. (b) Transmission map was constructed using genetic and epidemiology data from the outbreak iso-
lates, as detailed in Methods. Each node corresponds to an isolate(s) from an individual patient. Each bar represents a genetic change,
and the types of genetic change (recombination events, indels, non-synonymous SNPs, other SNPs) are differentiated by line colour/
style. Other SNPs, labelled as dashed lines, include synonymous SNPs and SNPs located in intergenic or promoter regions. Genes with
changes which alter protein sequence (i.e. non-synonymous changes) are annotated alongside the bar. Red text is used to highlight
known virulence genes.
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isolates identified only one deletion event for the pair of iso-
lates collected from P6. The deletion occurred in the pilE
and pilS genetic loci, a region known to be highly variable in
N. meningitidis. No differences were noted when comparing
the blood and CSF isolates from patients P3 or P7.
The CC41/44/Lineage3 is commonly associated with inva-
sive disease, but ST-409 is relatively rare. We, therefore,
sought to evaluate how these MnB outbreak isolates differed
from another ST-409 isolate (PMB5266) that had caused
sporadic disease. Using the PacBio long-read sequencing
platform, WGS data was also generated for the non-out-
break reference isolate PMB5266. From pairwise alignments
between PMB5026 (outbreak isolate) and PMB5266 (non-
outbreak isolate), 99.8% of the genomes are highly
Fig. 2. Whole-genome sequence based phylogeny and genetic transmission map among outbreak isolates from University B. (a) Maxi-
mum-likelihood phylogenetic tree generated using concatenated SNPs derived from genome-wide comparison (genetic changes asso-
ciated with recombination events excluded). Scale bar relates branch length to the number of genetic changes. PMB5018 represents
the outbreak-associated isolate, cultured from a patient nearly 8months before the first outbreak isolate. (b) The transmission map
was reconstructed using genetic and epidemiology data from the outbreak (or associated) isolates, as detailed in Methods. Each node
corresponds to an isolate from an individual patient. Each bar represents a genetic change, and the types of genetic change (recombi-
nation events, indels, non-synonymous SNPs, other SNPs) are differentiated by line colour/style. Other SNPs, labelled as dashed lines,
include synonymous SNPs and SNPs located in intergenic or promoter regions. Genes with changes which alter protein sequence (i.e.
non-synonymous changes) are annotated alongside the bar. Red text is used to highlight known virulence genes.
Hao et al., Microbial Genomics 2018;4
Downloaded from www.microbiologyresearch.org by
IP:  138.251.238.152
On: Wed, 18 Apr 2018 07:59:41
conserved, with an average of 99.2% sequence identity
across 38 conserved segments defined as locally collinear
blocks (LCBs) that lack genome rearrangements. Detailed
analysis uncovered a total of 17 recombination and 46 SNP/
indel events which differentiate the PMB5026 outbreak iso-
late from the reference PMB5266. Several of these differen-
ces are positioned in genes coding for meningococcal
virulence factors (e.g. fHBP, PorA, capsular polysaccharide)
(Fig. S1a, Tables S3 and S4).
Genetic analysis of University B outbreak isolates
Four MnB isolates were collected from students at Univer-
sity B, a single isolate from each of the four patients diag-
nosed with meningococcal disease during November 2013,
together with an outbreak-associated isolate (PMB5018)
collected 8months earlier during 2013 from a fifth patient
affiliated with the same university. Unlike the similar profile
identified among the University A outbreak isolates, the
four outbreak isolates from University B could be divided
into two groups based on different PFGE profiles (467, 468)
and PorB variant types (3–24, 3–461; Table 2). The out-
break-associated isolate PMB5018 shared the same profile
as one of the two groups (PFGE-467 and PorB 3–24). All
University B isolates were typed as ST-32 and CC32/ET5
complex, and contained genes that code for fHBP variant
B24, NadA variant 1, NHBA variant 5 and PorA type
P1.7,16-20 (Table 2).
WGS data for the four University B outbreak isolates and
the outbreak-associated isolate were generated using the
Illumina MiSeq short-read platform. The phylogenetic tree
using SNPs derived from WGS comparisons among the
four outbreak isolates (Fig. 2a) revealed two phylogenetic
clades, consistent with the PFGE and PorB typing results.
The genetic diversity within each of the two clades was small
and comparable with the genetic diversity observed among
the 11 isolates from the University A outbreak. The phylo-
genetic distance between the outbreak-associated isolate
PMB5018 and the outbreak isolates was greater than the
distance between the two outbreak clades (Fig. 2a). To accu-
rately describe the genetic evolution of the two University B
outbreak clades, a representative isolate from each was
sequenced using the PacBio long-read sequencing platform
(PMB4478 and PMB4479; Table S2). Unlike the University
A outbreak, the evolution of the University B outbreak iso-
lates was driven primarily by large recombination events
(spanning close to 100 kb and including nearly 80 genes)
(Fig. 2b). The two phylogenetic clades were the product of
six recombination events that span genomic regions
totalling >30 kb. The gene coding for PorB is located within
one of the recombination blocks, consistent with the differ-
ential porB genotype noted earlier. In addition to these
recombination events, 18 SNPs were identified among the
University B isolates, nine of which resulted in non-synony-
mous changes.
Collectively, isolates from the University B outbreak are
genetically related to isolates associated with prolonged
increased MnB disease incidence in Oregon (referred to as
the Oregon clone), sharing the same ST/CC and FetA and
fHBP variant types [30, 31]. A representative Oregon clone
(MnB strain M5178) was selected as a reference strain for
high-resolution whole-genome comparative analysis
with the University B outbreak isolate PMB4478. Syntenic
regions between the two disease-causing isolates were iden-
tified covering approximately 95% of the respective
genomes, with 99.8% pairwise nucleotide sequence identity.
Deep analysis uncovered a total of 20 recombination events
and 85 SNPs/indels that impacted >150 genes. Many of
these genes are known to code for proteins associated with
meningococcal virulence, including capD, porA, tbp2, pilE
and igA-specific serine endopeptidase [32] (Fig. S1b, Tables
S5 and S6).
DISCUSSION
Genetic characterization of disease-causing bacteria is fun-
damental for an understanding of pathogen evolution and
the epidemiology of disease. MLST and antigen typing
methods have been successfully exploited to characterize
many large collections of invasive meningococcal disease
(IMD) strains to probe molecular diversity from different
geographical regions [33, 34]. However, strains associated
with meningococcal disease outbreaks are typically highly
related [35] (i.e. the same sequence type and clonal com-
plex, ST/CC) and the detail afforded by these gene-based
sequence typing methods is insufficient for meaningful
comparative evaluation. WGS, powered by the rapid devel-
opment of high-throughput sequencing technology plat-
forms and de novo assembly algorithms, has been used
more recently to characterize closely related outbreak iso-
lates and study disease transmission [36–38]. While several
serogroup B disease outbreaks have been documented in
recent years in the USA and Europe [10, 11, 39, 40], com-
parative analysis of different outbreaks using WGS has not
been reported previously. In this study, we used WGS to
investigate the genetic diversity of MnB isolates from inde-
pendent meningococcal disease outbreaks that occurred at
two universities in the USA during 2013. While the out-
breaks occurred during the same calendar year among
individuals of the same age and with similar social
Table 2. Molecular typing results of University B outbreak and
outbreak-associated isolates*
Patient ID Strain ID Source of Specimen PorB PFGE
P1† PMB5018 Blood 3–24 467
P2 PMB4478 CSF 3–24 467
P3 PMB4477 Blood 3–24 467
P4 PMB4479 Blood 3–461 468
P5 PMB5019 Blood 3–461 468
*All isolates had the following profile: ST, ST-32; CC, CC32/ET5 com-
plex; fHBP variant, B24; NadA variant, 1; NHBA peptide, variant 5; PorA
variant type (VR1,VR2), P1.7,16-20; FetA variant type, F3-3.
†Outbreak-associated isolate.
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tendencies, comparative genomic analysis indicated that the
evolutionary patterns of the two collections of outbreak iso-
lates were considerably different from one another. Even
though the outbreak at University A was more protracted
than the outbreak at University B, isolates from the Univer-
sity A outbreak were considerably more homogeneous with
fewer SNP/indel changes. Conversely, the University B
outbreak isolates could be divided into two distinct subpo-
pulations distinguished from one another by large recombi-
nation events.
All isolates from the University A disease outbreak
were typed as ST-409, a single locus variant of ST-44 and
part of the ST-41/44/Lineage3 CC, one of the most preva-
lent and hypervirulent lineages globally since the 1970s [9,
41]. Although MnB disease outbreak strains typed as CC41/
44 have been reported, none have belonged to ST-409.
Among nearly 19 000 invasive meningococcal disease iso-
lates catalogued at PubMLST.org, only 28 are typed as ST-
409. Each of these is a serogroup B strain collected from
patients in Europe or northern Africa. Genetically distinct,
the University A outbreak strains and the ST-409 isolates at
PubMLST.org express different fHBP (B153 vs subfamily A
variants) and PorA variants. One of the University A out-
break strains (PMB5026) was sequenced using the PacBio
platform and used as a reference for detailed comparative
genomic analysis among all 11 outbreak isolates. A total of
just 18 SNPs, seven indels and one recombination event
were identified, an illustration of the clonal nature of the
University A outbreak isolates. Transmission of N. meningi-
tidis is via contact with droplets from the upper respiratory
tract, typically resulting in colonization and asymptomatic
carriage in otherwise healthy individuals. Under certain
instances that are not well understood, N. meningitidis is
capable of invading the human host, which then can mani-
fest as life-threatening invasive disease. With no docu-
mented evidence of direct contact among the University A
students diagnosed with meningococcal infections, the pro-
tracted course of the outbreak was consistent with multiple
independent clonal transmission events from asymptomatic
carriers in the population. In a recent study of a meningo-
coccal disease outbreak among members of a large extended
indigenous ethnic minority Traveller family [38], genotypes
consistent with the disease-causing strains were identified as
being carried asymptomatically in the population. Unfortu-
nately, a study to examine carriage isolates among students
at University A was not conducted.
The genome of N. meningitidis is highly dynamic, subject to
homologous recombination and horizontal gene transfer
events. Evidence of this was reported in the Traveller family
study [38], where genetic diversity was noted among disease
isolates, including potential evidence for inter-species hori-
zontal gene transfer. This is in marked contrast to the clonal
nature of the 11 disease isolates from the University A out-
break and the genetic stability of this outbreak cluster over
two academic years. Within the two central STs of the
ST41/44 clonal complex, ST-41 is largely associated with
invasive disease, whereas ST-44 is more often associated
with meningococcal carriage [42]. The ST-409 genotype of
the University A outbreak strains is a single locus variant of
ST-44 at pdhC, differing by just seven nucleotide substitu-
tions each resulting in a synonymous change. Despite the
prolonged epidemiologic persistence of ST-44 among
asymptomatic N. meningitidis carriage isolates, disease
outbreaks associated with ST-44 (or related STs, such as ST-
409) have been rare.
Each of the University B outbreak and outbreak-associated
isolates belongs to the ST-32/ET-5 clonal complex, a clonal
complex associated with meningococcal disease since the
1970s, including a persistent epidemic in Norway that
spanned >20 years [43] as well as prolonged MnB disease
incidence in Oregon [30]. In contrast to the genetic homo-
geneity among University A outbreak isolates, isolates in the
University B disease outbreak could be grouped into two
phylogenetic clades, initially differentiated by their PFGE
profile (types 467 and 468) and PorB variant type (3-24 and
3-461). Deeper analysis of WGS data from University B
isolates uncovered six recombination events
encompassing >30 kb (>1% of genome) that differentiated
the two clades from one another. Two of these recombina-
tion events each span regions >10 kb, a length which is
much greater than the average recombination length for
N. meningitidis, previously estimated to be 1.1 kb [44]. The
four University B disease cases were diagnosed within a
month of one another, and isolates representative of the two
clades (PMB4477 and PMB4479) were cultured from
patients with disease onset <1week apart. There was no
direct contact among any of the University B cases. Given
this abbreviated timeline, it is likely that meningococci from
both clades were circulating simultaneously among asymp-
tomatic carriers in the population. Unfortunately, contem-
poraneous carriage isolates from asymptomatic University
B students were not collected to provide additional insight.
The evolutionary dynamics of an outbreak can be shaped by
several factors, including mutation rate, mode of transmis-
sion, adaptation to host environment and stochastic events.
Owing to the extreme complexity of within-host evolution,
it is challenging to identify the factor(s) primarily contribut-
ing to the distinct evolutionary patterns of these two Uni-
versity outbreaks. Main limitations of this study are that the
sample size of each outbreak was small and asymptomatic
carriage samples were not collected to permit a comparison
with invasive cases.
Generally, meningococci associated with epidemics and out-
breaks belong to more uniform clonal groups, compared
with meningococci causing sporadic disease [45]. However,
differences between sporadic disease and outbreak isolates
from the same ST/CC group are poorly understood. Here,
genetic differences (SNPs/indels) distinguishing the out-
break isolates from the two universities and the respective
reference disease isolates were compiled (Tables S3–S6).
Where available, the presumptive functions of the proteins
identified in this comparative analysis were grouped into
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four categories: (i) surface/capsule/virulence factors, (ii)
metabolism/pathway, (iii) transcription/translation/signal-
ling and (iv) transport/other (Table S7). Included on this
list are known virulence factors that mediate attachment of
N. meningitidis to mucosal cells of the nasopharynx (e.g.
pilin and associated surface proteins) and, therefore, coloni-
zation [32]. Similarly, antibiotic resistance resulting from
the modification or regulation of efflux pump components
can promote bacterial survival in the presence of therapeutic
pressure [46]. The distribution of genetic events that differ-
entiate the two collections of university outbreak isolates
from the respective reference isolates among the four cate-
gories was similar for both disease outbreaks (Table S7).
Specifically, genes related to intra- and extra-cellular signal-
ling (including transcription and translation machinery)
were most often identified as being different in the compari-
son between outbreak and the respective non-outbreak iso-
lates. For each outbreak, only 9–12% of the proteins
impacted were related to modifications of surface and cap-
sule proteins or virulence-associated factors, six of which
were common to both outbreaks. These shared virulence
factors include porA, mviN, icsA, pilC, ctrD and ostA, with
most of the changes associated with the postulated genetic
recombination events. Any link between these genetic
differences and disease transmission remains to be
demonstrated experimentally.
In contrast to the low discriminating power afforded by
conventional typing methods (PFGE and MLST), WGS can
provide the genetic fingerprint of an isolate. In this study,
we took advantage of a hybrid WGS approach, using two
sequencing platforms (PacBio and Illumina). Relatively
inexpensive, Illumina sequencing was used to rapidly assess
the relatedness of disease isolates. PacBio WGS of a repre-
sentative isolate was used to generate a reference sequence,
against which specific changes among related strains were
identified and potentially associated with phenotype. There
was high concordance across WGS data for the majority of
isolates that were sequenced using both platforms
(Table S8). Interestingly, ~5% (120 kb) of the PMB5019
PacBio genome was not well covered by the Illumna MiSeq
reads, an observation that highlights the value of obtaining
reference genomes from long-read sequencing technology
for this type of detailed analysis.
In response to the meningococcal disease outbreaks at both
University A and B, two MnB vaccines, Trumenba (bivalent
rLP2086) and Bexsero (4CMenB), were granted accelerated
approval by the FDA in October 2014 and February 2015,
respectively [6, 7]. The outer-membrane protein fHBP is an
antigen included in both vaccines. Detailed epidemiological
studies have illustrated that the gene coding for fHBP is
present in the majority of MnB isolates [33, 47]. Expression
and accessibility of the vaccine antigen on the bacterial
pathogen to the host immune system is critical for vaccine-
elicited antibodies to kill disease-causing meningococci
[48]. Robust fHBP surface expression was detected on out-
break isolates from both University A and University B
[49]. In exploratory serum bactericidal assays using human
complement (hSBAs), sera from individual subjects vacci-
nated with Trumenba were able to kill representative
outbreak strains from University A and B (hSBA response
rates of 44.4–77.8 and 77.8–100% following 2 and 3 doses,
respectively) [49]. These data illustrate the functional activ-
ity elicited by Trumenba against strains expressing fHBP
variants heterologous to the vaccine antigens (variant B153
from University A and variant B24 from University B).
While there is no hSBA data available with Bexsero immune
sera and the outbreak isolate from University B, a recent
analysis revealed that 66.1% of students vaccinated at Uni-
versity A were seropositive in hSBA against a representative
University A outbreak strain after receiving two doses of the
vaccine [50].
To our knowledge, this is the first comparison of the evolu-
tion of isolates from two independent MnB disease out-
breaks. Disease isolates from the University A outbreak
were clonal in nature. Illustrating the differential evolution-
ary patterns between these two outbreaks, the isolates col-
lected in the University B outbreak could be divided to two
phylogenetic clades, the product of several independent
recombination events. We identified genetic changes associ-
ated with virulence factors and outer-membrane proteins.
This study also illustrated the value of a hybrid WGS
approach that combines long- and short-read sequencing
technologies in the genetic investigation of disease
outbreaks.
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